Stacey Pereira

This study explores adult perspectives on psychiatric polygenic risk scores through interviews, highlighting both potential benefits and concerns about their use.

The paper examines motivations and outcomes of elective genomic sequencing across research, clinical, and commercial contexts, finding most participants found results medically important but few shared them with healthcare providers.

The paper develops a comprehensive list of genetic conditions for genomic newborn screening, including 777 conditions associated with 743 genes, for implementation across multiple U.S. states and territories.

The paper explores parental perspectives on genomic sequencing research participation among under-represented racial and ethnic groups, finding high interest but identifying barriers to enrollment.

This study compares clinician and patient perspectives on polygenic embryo screening, finding divergent views on its use and ethical implications.

The paper surveys U.S. public attitudes toward polygenic embryo screening, finding high approval and interest despite concerns about eugenics and false expectations.

The paper evaluates unanticipated monogenic disease risks found in newborns through genomic screening, finding most risks are actionable and lead to medical interventions.

The paper surveys psychiatric genetics researchers on their return of results practices, finding support for returning medically relevant findings but lacking adequate guidelines and knowledge.

This study surveys global psychiatric genetics researchers on best practices for returning genetic results related to psychiatric disorders, identifying challenges and preferred disclosure methods.